BioHelix Corporation - Product Pipeline Analysis

GlobalData
November 28, 2012
24 Pages - SKU: GBDT4925478


Summary

BioHelix Corporation (BioHelix) is a privately held molecular diagnostic company, based in the US. It develops and markets generation diagnostic solutions and nucleic acid tests based upon its isothermal nucleic acid amplification platform for the treatment of infectious diseases and for genetic variations. The company develops products such as diagnostic products, which include isoamp on demand assays, and general purpose reagents; isothermal nucleic acid amplification consists of rapisome pwga kit-whole genome amplification, and isoamplll thda kit-robust target amplification; and primer navigator DNA amplification enhancers. BioHelix’s products also include helicases comprising thermostable DNA helicase, and mesophilic DNA helicase. It is developing a portfolio of proprietary technologies for nucleic acid analysis and molecular diagnostics using internal research and in-licensing of new technology. The company has two isothermal amplification platforms, the target based-Helicase Dependant Amplification platform (HDA) and the primase-based Whole Genome Amplification platform (pWGA). Biohelix is headquartered in Beverly, Massachusetts, the US.

This report is a source for data, analysis and actionable intelligence on the BioHelix Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.



More B - Companies reports by GlobalData

Black Ridge Oil & Gas Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2014 by GlobalData
Black Ridge Oil & Gas Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2014SummaryBlack Ridge Oil & Gas Inc. Oil ...
BMC Software, Inc. (BMC) - Strategic SWOT Analysis Review by GlobalData
BMC Software, Inc. (BMC) - Strategic SWOT Analysis Review - provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. ...
Brocade Communications Systems, Inc. (BRCD) - Financial and Strategic SWOT Analysis Review by GlobalData
Brocade Communications Systems, Inc. (BRCD) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses ...
Boralex Inc. (BLX) - Financial and Strategic SWOT Analysis Review by GlobalData
Boralex Inc. (BLX) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 750  
    Site License  USD 1,500  
    Global Site License  USD 2,250  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!